Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines
暂无分享,去创建一个
Rui Li | Jiafu Ji | Samuel So | S. So | J. Ji | Xin Chen | S. Leung | S. Yuen | K. Chu | Rui Li | J. Chi | Ji‐you Li | Xin Chen | Jiyou Li | Nina Dunphy | J. Chi | Suet Yi Leung | Siu Tsan Yuen | Jen-Tsan A Chi | Kent Man Chu | Annie SY Chan | K. Chu | Annie S. Y. Chan | N. Dunphy
[1] T. Poggio,et al. Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] T. Okuda,et al. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c‐erbb‐2 in human gastric cancer , 1995, Cancer.
[3] Ash A. Alizadeh,et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays , 1999, Nature Genetics.
[4] G. Berx,et al. The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. , 1999, Molecular cell biology research communications : MCBRC.
[5] Christian A. Rees,et al. Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.
[6] G. Martinelli,et al. Villin, intestinal brush border hydrolases and keratin polypeptides in intestinal metaplasia and gastric cancer; an immunohistologic study emphasizing the different degrees of intestinal and gastric differentiation in signet ring cell carcinomas , 2004, Virchows Archiv A.
[7] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[8] D. Botstein,et al. A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.
[9] D A Scudiero,et al. The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. , 1997, Anti-cancer drug design.
[10] H. Yokozaki,et al. Molecular characteristics of eight gastric cancer cell lines established in Japan , 2000, Pathology international.
[11] J. Ferlay,et al. Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18–29 (1999). , 1999, International journal of cancer.
[12] M. Mareel,et al. The role of the E-cadherin/catenin complex in gastrointestinal cancer. , 1999, Acta gastro-enterologica Belgica.
[13] Jacques Ferlay,et al. Estimates of the worldwide incidence of 25 major cancers in 1990 , 1999, International journal of cancer.
[14] J. Mesirov,et al. Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Ferlay,et al. Estimates of the worldwide mortality from 25 cancers in 1990 , 1999, International journal of cancer.
[16] D. Lockhart,et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Holt,et al. Genetics of gastric cancer. , 1995, Anticancer research.
[18] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[19] P. Malfertheiner,et al. Molecular alterations in gastric cancer: the role of Helicobacter pylori. , 2000, European journal of gastroenterology & hepatology.
[20] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[21] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.